Evidence map›Paper›PMID 27313475›Full record

ArticleBreast cancer (Dove Medical Press)2016

The absence of aldehyde dehydrogenase 1 A1-positive cells in benign mammary stroma is associated with risk factors for breast cancer.

Björn Logi Isfoss, Bo Holmqvist, Helena Jernström, Per Alm, Håkan Olsson

Open access · goldAbstract read
In one paragraph

Article in Breast cancer (Dove Medical Press), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Björn Logi IsfossDepartment of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Department of Pathology, Skane University Hospital, Lund, Sweden; Department of Pathology, Telemark Hospital, Skien, Norway.
Bo HolmqvistDepartment of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; ImaGene-iT AB, Medicon Village, Lund, Sweden.
Helena JernströmDepartment of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Per AlmDepartment of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Håkan OlssonDepartment of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Division of Cancer Epidemiology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University · SEMedicon Village · SETelemark Hospital · NO

Funding

European Research Council 294576
6 · The paper itself

Abstract

In this study, aldehyde dehydrogenase 1 (ALDH1)-expressing cells in stroma of histologically normal breast tissue from premenopausal women were investigated in situ regarding cellular morphology, cell distribution, and relation to the additional stem cell markers, CD44 (+) and CD24 (-). These results were correlated with hormonal and genetic risk factors for breast cancer. Triple immunofluorescence labeling was performed on tissues from premenopausal women with a family history of breast cancer, and breast reduction specimens from premenopausal women with no family history of breast cancer were used as a control group. The majority of ALDH1-immunoreactive cells in stroma were spindle-shaped or polygonal, and such cells that were CD44(-) and CD24(-) were absent in the breast stroma of a significantly larger number of nulliparous than parous women. A less common morphological type of ALDH1-positive cells in stroma was round or oval in shape, and such cells that were CD44(+) and CD24(-) were absent in a significant number of women with a family history of breast cancer. The CD44(+)/CD24(-) immunophenotype is consistent with stem cells, and the round/oval morphology suggests mesenchymal cells. This study demonstrates that there are two morphologically distinct types of ALDH1-positive cells in histologically benign mammary stroma, and the absence of these cells is correlated with clinical risk factors for breast cancer in premenopausal women.

Indexed as

BRCA1 genehumanimmunohistochemistrymammary glandsneoplasmsstem cells

Identifiers

PMID27313475
PMCPMC4890687
OpenAlexW2415892070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.